Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Bücher"
topic_facet:"Diabetes Mellitus, Type 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+B%C3%BCcher%22&filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Drug+Combinations%22&type0%5B%5D=Subject&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+B%C3%BCcher%22&filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Drug+Combinations%22&type0%5B%5D=Subject&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+B%C3%BCcher%22&filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Drug+Combinations%22&type0%5B%5D=Subject&op0%5B%5D=OR
PubPharm (10)
1
Clinical review report : (Novo nordisk Canada Inc.)Insulin degludec and liraglutide injection (Xultophy)
Erschienen: Ottawa (ON),
CADTH,
December 2019
CADTH common drug review
Version: final (with redactions).
Wird geladen...
2
Pharmacoeconomic review report : Insulin degludec and liraglutide injection (Xultophy) (Novo Nordisk Canada Inc.)
Erschienen: Ottawa (ON),
CADTH,
December 2019
CADTH common drug review
Version: Final (with redactions).
Wird geladen...
3
CADTH Canadian Drug Expert Committee recommendation : indication : adjunct to lifestyle modifications, for the once-daily treatment of adults with type 2 diabetes mellitus (T2DM) to improve glycemic control in combination with metformin, with or without sulfonylurea, when these combined with basal insulin (less than 50 units daily) or liraglutide (less than or equal to 1.8 mg daily), do not provide adequate glycemic controlInsulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.)
Erschienen: Ottawa (ON),
CADTH,
October 2019
CADTH common drug review
Version: 1.0.
Wird geladen...
4
Common drug review new combination product : indication : type 2 diabetes mellitusErtugliflozin/Metformin fixed-dose combination (Segluromet) Merck Canada Inc
Erschienen: Ottawa (ON),
CADTH,
February 2019
CADTH common drug review
Final (with redactions).
Wird geladen...
5
CADTH Canadian Drug Expert Committee recommendation : indication : diabetes mellitus, type 2Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.)
Erschienen: Ottawa (ON),
CADTH,
January 25, 2019
CADTH common drug review
Final.
Wird geladen...
6
Clinical review report : indication : adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) alone or in combination with metforminInsulin glargine and lixisenatide injection (Soliqua) (Sanofi-Aventis)
Erschienen: Ottawa (ON),
CADTH,
January 2019
CADTH common drug review
Final (with redactions).
Wird geladen...
7
Pharmacoeconomic review report : indication : adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) alone or in combination with metforminInsulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis)
Erschienen: Ottawa (ON),
CADTH,
January 2019
CADTH common drug review
Final (with redactions).
Wird geladen...
8
Pharmacoeconomic review report : Empagliflozin and Metformin fixed-dose combination (Synjardy)
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
September 2017
CADTH common drug review
Wird geladen...
9
CADTH Canadian Drug Expert Committee final recommendation : Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
April 27, 2016
Common drug review
Wird geladen...
10
CADTH Canadian Drug Expert Committee final recommendation : indication : type 2 diabetes mellitusEmpagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.)
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
October 25, 2016
Common drug review
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Books
Filter aufheben
Thema: Diabetes Mellitus, Type 2
Medienart
10
Bücher
E-Books
10
E-Ressourcen
Thema
Diabetes Mellitus, Type 2
10
Drug Combinations
10
drug therapy
9
therapeutic use
7
Hypoglycemic Agents
5
Metformin
4
Insurance, Health, Reimbursement
4
Sodium-Glucose Transporter 2 Inhibitors
4
economics
3
Blood Glucose
3
Cost-Benefit Analysis
3
Insulin, Long-Acting
3
Liraglutide
3
drug effects
2
Bridged Bicyclo Compounds, Heterocyclic
2
Comparative Effectiveness Research
2
Drug Costs
2
Treatment Outcome
1
Glucosides
1
Quality-Adjusted Life Years
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2019
1
2017
2
2016
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...